Chris Davis: Navigating Todays Turbulent Markets With Bill Miller

Two legendary portfolio managers, Chris Davis and Bill Miller, engaged in a comprehensive discussion about navigating today’s volatile investment landscape, drawing from their combined decades of experience managing billions in assets.

The conversation, structured around nine key topics, covers everything from investment temperament and market volatility to emerging technologies and geopolitical challenges. Miller, famous for outperforming the S&P 500 for 15 consecutive years while managing the Legg Mason Value Trust, and Davis share insights on stewardship, patience, and contrarian investing approaches. The discussion emphasizes the importance of long-term thinking, adaptability, and maintaining perspective during uncertain times.

Both veterans stress that successful investing requires going against conventional wisdom, focusing on free cash flow yields, and understanding that bear markets often present the best opportunities for wealth creation. They explore specific examples including Amazon and General Electric to illustrate how management decisions can create or destroy business value over time. The conversation concludes with their optimistic outlook on the next decade, highlighting opportunities created by technological breakthroughs and market uncertainties.

Here are the key takeaways:

  • Experience and temperament matter more than forecasting: Both Davis and Miller emphasize that successful investing comes from having the right temperament to go against the crowd and maintain patience during volatile periods, rather than trying to predict market movements.
  • Bear markets create wealth, not bull markets: The legendary investors stress that “you make most of your money in a bear market, you just don’t realize it at the time,” highlighting the importance of maintaining long-term perspective during downturns.
  • Free cash flow yield reveals true business value: Miller and Davis identify this often-overlooked metric as a crucial indicator for assessing whether a business is truly undervalued or overvalued in the current market environment.
  • AI revolution winners remain uncertain: While acknowledging AI’s transformative potential, both managers caution that the current leaders in any technological revolution don’t always emerge as the ultimate winners, emphasizing the need for adaptability over speculation.
  • Cash is not a safe haven: The investment veterans warn that holding cash may feel safer but inflation systematically destroys purchasing power over time, while quality equities build genuine long-term wealth.

Share the news

Disclaimer of liability

The above has been prepared by Børsgade ApS for information purposes and cannot be regarded as a solicitation or recommendation to buy or sell any security. Nor can the information etc. be regarded as recommendations or advice of a legal, accounting or tax nature. Børsgade cannot be held liable for losses caused by customers’/users’ actions – or lack thereof – based on the information in the above. We have made every effort to ensure that the information in the above is complete and accurate, but cannot guarantee this and accept no liability for errors or omissions.

Readers are advised that investing may involve a risk of loss that cannot be determined in advance, and that past performance and price development cannot be used as a reliable indicator of future performance and price development. For further information please contact info@borsgade.dk

You might also find this interesting:

Warren Buffett: Lessons from the Oracle of Omaha

In this special celebratory episode from The Investor’s Podcast, host William Green shares his personal observations from attending the annual shareholder meeting in Omaha where the announcement was made, describing it as the most joyful meeting he’s ever attended.

The episode features powerful highlights from Green’s previous conversations with legendary investors including Joel Greenblatt, Nick Sleep, Thomas Russo, Chris Davis, Chuck Akre, and Christopher Bloomstran, all discussing Buffett’s profound influence on their investment approaches.

Chris Davis: Navigating Todays Turbulent Markets With Bill Miller

Two legendary portfolio managers, Chris Davis and Bill Miller, engaged in a comprehensive discussion about navigating today’s volatile investment landscape, drawing from their combined decades of experience managing billions in assets.

The conversation, structured around nine key topics, covers everything from investment temperament and market volatility to emerging technologies and geopolitical challenges. Miller, famous for outperforming the S&P 500 for 15 consecutive years while managing the Legg Mason Value Trust, and Davis share insights on stewardship, patience, and contrarian investing approaches. The discussion emphasizes the importance of long-term thinking, adaptability, and maintaining perspective during uncertain times.

Michael Mauboussin: Drawdowns Are The Unavoidable Cost of Long-Term Investing

Michael Mauboussin from Morgan Stanley Investment Management have published a comprehensive analysis examining stock market drawdowns and recovery patterns from 1985 to 2024. The research reveals that even the most successful investments experience severe price declines, with the median stock suffering an 85% drawdown that takes 2.5 years from peak to trough.

The study analyzed over 6,500 companies and found that more than half never recover to their previous highs. Michael’s work demonstrates that large drawdowns are an inevitable feature of equity investing, affecting individual stocks, mutual funds, and even portfolios with perfect foresight.

Thomas Gayner: My Current Take on Novo Nordisk

In his interview, Tom Gayner, CEO of Markel Group, reflects on investment principles shaped by Warren Buffett and Charlie Munger, and offers a detailed assessment of Novo Nordisk. Gayner praises Novo Nordisk for its business quality, global leadership in diabetes treatment, and strong growth trajectory. He credits the company’s disciplined management and innovation in pharmaceuticals as exemplary, aligning with his own standards of long-term value creation.